- Home
- NIU vs GOSS Comparison
NIU vs GOSS Comparison
Compare NIU & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NIU
- GOSS
- Stock Information
- Founded
- NIU 2014
- GOSS 2015
- Country
- NIU China
- GOSS United States
- Employees
- NIU N/A
- GOSS N/A
- Industry
- NIU Auto Manufacturing
- GOSS Biotechnology: Pharmaceutical Preparations
- Sector
- NIU Consumer Discretionary
- GOSS Health Care
- Exchange
- NIU Nasdaq
- GOSS Nasdaq
- Market Cap
- NIU 216.7M
- GOSS 203.3M
- IPO Year
- NIU 2018
- GOSS 2019
- Fundamental
- Price
- NIU $3.47
- GOSS $1.16
- Analyst Decision
- NIU
- GOSS Strong Buy
- Analyst Count
- NIU 0
- GOSS 4
- Target Price
- NIU N/A
- GOSS $7.75
- AVG Volume (30 Days)
- NIU 1.2M
- GOSS 1.5M
- Earning Date
- NIU 05-19-2025
- GOSS 05-15-2025
- Dividend Yield
- NIU N/A
- GOSS N/A
- EPS Growth
- NIU N/A
- GOSS N/A
- EPS
- NIU N/A
- GOSS N/A
- Revenue
- NIU $477,578,753.00
- GOSS $124,590,000.00
- Revenue This Year
- NIU $41.32
- GOSS N/A
- Revenue Next Year
- NIU $24.38
- GOSS $190.37
- P/E Ratio
- NIU N/A
- GOSS N/A
- Revenue Growth
- NIU 26.51
- GOSS N/A
- 52 Week Low
- NIU $1.65
- GOSS $0.50
- 52 Week High
- NIU $4.90
- GOSS $1.55
- Technical
- Relative Strength Index (RSI)
- NIU 48.06
- GOSS 55.35
- Support Level
- NIU $3.53
- GOSS $1.09
- Resistance Level
- NIU $4.16
- GOSS $1.20
- Average True Range (ATR)
- NIU 0.32
- GOSS 0.09
- MACD
- NIU -0.01
- GOSS 0.00
- Stochastic Oscillator
- NIU 31.37
- GOSS 69.01
About NIU Niu Technologies
Niu Technologies designs, manufactures and sells high-performance electric motorcycles, scooters, bicycles, and kick-scooters. The company has a product portfolio consisting of electric motorcycle, mopeds and bicycle series, including the NQi, MQi, UQi, F series, and others, and micro-mobility series, including the kick-scooter series KQi and the e-bike series BQi. The company's principal operations and geographic markets are predominantly in the People's Republic of China. It also generates revenue from Europe and other regions.
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.